These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 15519026)

  • 21. Unusual cause for an increase of the sensing integrity counter in a patient with inappropriate implantable cardioverter-defibrillator therapy.
    Vollmann D; Lüthje L; Zabel M
    Europace; 2007 May; 9(5):275-7. PubMed ID: 17369268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electromagnetic interference from welding and motors on implantable cardioverter-defibrillators as tested in the electrically hostile work site.
    Fetter JG; Benditt DG; Stanton MS
    J Am Coll Cardiol; 1996 Aug; 28(2):423-7. PubMed ID: 8800120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple appropriate and spurious defibrillator shocks in a patient with right ventricular cardiomyopathy.
    Strohmer B; Schernthaner C; Pichler M
    Int J Cardiol; 2005 Jul; 102(2):363-6. PubMed ID: 15982515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inappropriate implantable cardioverter-defibrillator discharges unrelated to supraventricular tachyarrhythmias.
    Occhetta E; Bortnik M; Magnani A; Francalacci G; Marino P
    Europace; 2006 Oct; 8(10):863-9. PubMed ID: 16916859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The 1+1 trial: a prospective trial of a dual- versus a single-chamber implantable defibrillator in patients with slow ventricular tachycardias.
    Bänsch D; Steffgen F; Grönefeld G; Wolpert C; Böcker D; Mletzko RU; Schöls W; Seidl K; Piel M; Ouyang F; Hohnloser SH; Kuck KH
    Circulation; 2004 Aug; 110(9):1022-9. PubMed ID: 15326069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-determinable defibrillation threshold and inefficacy of implantable cardioverter/defibrillator shocks due to defective connections of the defibrillator lead terminals in the device header port.
    Maagh P; Trappe HJ; Meissner A
    Europace; 2007 Dec; 9(12):1161-2. PubMed ID: 17913694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Daubert JP; Zareba W; Hall WJ; Schuger C; Corsello A; Leon AR; Andrews ML; McNitt S; Huang DT; Moss AJ;
    J Am Coll Cardiol; 2006 Jan; 47(1):98-107. PubMed ID: 16386671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Automatic R-wave and impedance testing with the modern patient alert system to reduce inappropriate implantable cardioverter defibrillator shocks due to lead fracture.
    Chinushi M; Hosaka Y; Ikarashi N; Iijima K; Furushima H; Aizawa Y
    Europace; 2008 Jun; 10(6):738-40. PubMed ID: 18390874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of pacing/defibrillator lead failure using device diagnostics and pacing maneuvers.
    Chung EH; Casavant D; John RM
    Pacing Clin Electrophysiol; 2009 Apr; 32(4):547-9. PubMed ID: 19335868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance of a new single-chamber ICD algorithm: discrimination of supraventricular and ventricular tachycardia based on vector timing and correlation.
    Corbisiero R; Lee MA; Nabert DR; Coman JA; Breiter DJ; Schwartz M; McKittrick E; Zhang Y
    Europace; 2006 Dec; 8(12):1057-61. PubMed ID: 17105781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective experience with the lead integrity alert: new certainties and new uncertainties.
    Koenig T; Gardiwal A; Oswald H; Klein G
    Europace; 2009 Nov; 11(11):1549-51. PubMed ID: 19666640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spectrum of issues detected by an ICD diagnostic alert that utilizes far-field electrograms: Clinical implications.
    Koneru JN; Kaszala K; Bordachar P; Shehata M; Swerdlow C; Ellenbogen KA
    Heart Rhythm; 2015 May; 12(5):957-67. PubMed ID: 25640632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of a discrimination algorithm to reduce inappropriate shocks with a subcutaneous implantable cardioverter-defibrillator.
    Gold MR; Weiss R; Theuns DA; Smith W; Leon A; Knight BP; Carter N; Husby M; Burke MC
    Heart Rhythm; 2014 Aug; 11(8):1352-8. PubMed ID: 24732366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
    Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L
    Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple ICD discharges associated with lead fracture without triggering of high impedance alert.
    Donaldson DM; Singh JP; Heist EK; Mela T; Ruskin JN; Das S
    Pacing Clin Electrophysiol; 2009 Apr; 32(4):543-6. PubMed ID: 19335867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subcutaneous Implantable Cardioverter Defibrillator Lead Repositioning for Preventing Inappropriate Shocks Due to Myopotential Oversensing in a Post-Fulminant Myocarditis Patient.
    Sasaki T; Nakamura K; Naito S
    Int Heart J; 2019 Mar; 60(2):466-469. PubMed ID: 30745542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of atrial activity from high-voltage leads of implantable ventricular defibrillators using a cancellation technique.
    Shkurovich S; Sahakian AV; Swiryn S
    IEEE Trans Biomed Eng; 1998 Feb; 45(2):229-34. PubMed ID: 9473845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraoperative comparison of a subthreshold test pulse with the standard high-energy shock approach for the measurement of defibrillation lead impedance.
    Schuchert A; Winter J; Binner L; Kühl M; Meinertz T;
    J Cardiovasc Electrophysiol; 2006 Jan; 17(1):56-9. PubMed ID: 16426402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.